Print Friendly, PDF & Email

NCT/Study#

NCT03712605 /

EA6174

STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial

DISEASE GROUP:

Skin and Soft Tissue

current phase:

Phase III

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587